1. Home
  2. CJET vs XBIO Comparison

CJET vs XBIO Comparison

Compare CJET & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chijet Motor Company Inc.

CJET

Chijet Motor Company Inc.

HOLD

Current Price

$0.87

Market Cap

5.0M

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

N/A

Current Price

$2.41

Market Cap

5.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CJET
XBIO
Founded
2009
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
5.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CJET
XBIO
Price
$0.87
$2.41
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
3.0M
47.5K
Earning Date
03-26-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,107,000.00
$2,858,935.00
Revenue This Year
N/A
$1.99
Revenue Next Year
N/A
$20.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.30
52 Week Low
$0.82
$2.20
52 Week High
$299.00
$13.93

Technical Indicators

Market Signals
Indicator
CJET
XBIO
Relative Strength Index (RSI) 38.48 40.78
Support Level $0.82 $2.31
Resistance Level $1.28 $2.64
Average True Range (ATR) 0.29 0.18
MACD -0.14 0.05
Stochastic Oscillator 2.07 31.65

Price Performance

Historical Comparison
CJET
XBIO

About CJET Chijet Motor Company Inc.

Chijet Motor Company Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from PRC.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: